Skip to main content

Dearborn Partners LLC

SEC CIK
0001206792
Latest filing
Aug 14, 2026

IGC holding history

IGC Pharma, Inc. in every 13F filed by Dearborn Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IGC overviewAll 13F holders of IGCFull Q2 2026 holdings

Shares (Q2 2026)
59,401
Value
$16.2K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IGC by Dearborn Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202659,401$16.2K<0.1%00.0%UnchangedHolders
Q1 202659,401$15.6K<0.1%−25,000−29.6%ReducedHolders
Q4 202584,401$23.8K<0.1%00.0%UnchangedHolders
Q3 202584,401$35.2K<0.1%00.0%UnchangedHolders
Q2 202584,401$25.8K<0.1%00.0%UnchangedHolders
Q1 202584,401$24.1K<0.1%−25,000−22.9%ReducedHolders
Q4 2024109,401$36.8K<0.1%−7,000−6.0%ReducedHolders
Q3 2024116,401$49.7K<0.1%00.0%UnchangedHolders
Q2 2024116,401$50.5K<0.1%−309−0.3%ReducedHolders
Q1 2024116,710$46.7K<0.1%00.0%UnchangedHolders
Q4 2023116,710$32.7K<0.1%00.0%UnchangedHolders
Q3 2023116,710$41.9K<0.1%00.0%UnchangedHolders
Q2 2023116,710$36.4K<0.1%00.0%UnchangedHolders
Q1 2023116,710$39.6K<0.1%−17,691−13.2%ReducedHolders
Q4 2022134,401$42.8K<0.1%00.0%UnchangedHolders
Q3 2022134,401$58.0K<0.1%+9,375+7.5%AddedHolders
Q2 2022125,026$66.0K<0.1%+28,125+29.0%AddedHolders
Q1 202296,901$92.0K<0.1%00.0%UnchangedHolders
Q4 202196,901$95.0K<0.1%00.0%UnchangedHolders
Q3 202196,901$143.0K<0.1%00.0%UnchangedHolders
Q2 202196,901$159.0K<0.1%00.0%UnchangedHolders
Q1 202196,901$173.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.